Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
LODH Immunology Fund
investment firm
About
The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank.
- Geneva,Geneve,Switzerland
Highlights
Details
- Operating Status
- Active
- Investor Type
- Investment Bank
The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank. Approximately 20% of the assets of the fund are invested in privately held biotech companies.
Investments
Number of Investments
Number of Lead Investments
6
1
LODH Immunology Fund has made 6 investments. Their most recent investment was on
May 12, 2009, when NovImmune raised $54.80M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 12, 2009
NovImmune
|
Series Unknown | $54.80M | Biotechnology | — |
|
Jun 1, 2006
NovImmune
|
Series B | $46M | Biotechnology | — |
|
May 14, 2002
ESBATech
|
Series A | Fr14.50M | Biotechnology | Yes |
|
Sep 27, 2001
7TM Pharma
|
Series A | $15M | Biotechnology | — |
|
Jun 13, 2000
|
Series Unknown | $40.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
